@KolPulseAI

Instant insights from oncology’s top voices. Download the free Chrome Extension that tracks trials, sentiment & influence on X.

 Savannah, GA
kolpulse.com
Joined August 2023
  • Tweets14.9K
  • Following4.8K
  • Followers1.2K
450Media

Summit's Dr. Jack West Challenges #WCLC25 Discussant Over "Biased" HARMONi Commentary

by Brian Shields

Article · @KolPulseAI
2
1
3
2
2,952

FLAURA 2 and MARIPOSA: Did Dr. Vinay Prasad get it right?

written by Brian Shields (@MrPug94)

Article · @KolPulseAI
1
1
432

FLAURA2 Discussions by TOP KOLS in NSCLC since 2023

@AstraZenecaUS just announced the positive OS results of their trial FLAURA2.

Article · @KolPulseAI
1
3
927

Top 10 Tweets from #ESMOGI25

shared by @SuyogCancer

Article · @KolPulseAI
1
401

Top 7 Discussions from #ESMOGI25

Top 7 discussions from #ESMOGI25:

Article · @KolPulseAI
1
1
459

Did ATOMIC and MATTERHORN bring more Questions than Answers at #ASCO25

Prior to #ASCO25, the ATOMIC (@Roche, @genentech) and MATTERHORN (@AstraZenecaUS) trials were both hailed as exciting #ASCO25 plenary sessions for the GI @ASCO community across the globe.

Article · @KolPulseAI
2
92

Should KOLs Boycott OncLive at #ASCO25?

Author: Brian Shields

Article · @KolPulseAI
1
3
2
8
7,352

What May #ASCO25 Expect from Dr. Vinay Prasad at the FDA?

The FDA Commissioner, Dr. Martin Makary has just named Hematologist/Oncologist Dr. Vinay Prasad (@VPrasadMDMPH) from @UCSF to lead the FDA's Center for Biologics Evaluation and Research (CBER), a ve…

Article · @KolPulseAI
1
2
3
2,381

HARMONi-2 Journal Club

🐝📢 HARMONi-2 Journal Club: Is There a New Queen in Town? 👑

Article · @KolPulseAI
1
1
1
1
1,309

DESTINY-Gastric04 Social Media Analysis

DESTINY-Gastric04 Trial: Key Findings and Social Media Reactions

Article · @KolPulseAI
1
2
1
5
1,629

Key Themes of the #TTLC25 Lung Cancer Meeting of Experts

The evolving landscape of EGFR-mutated NSCLC treatment emerged as a central focus, with Dr. Julia Rotow @JuliaRotow highlighting critical considerations in treatment sequencing. The discussion emphas…

Article · @KolPulseAI
2
1
1
499

Dato-DXd Approved by FDA, What Have Key Opinion Leaders been Saying about TROPION-Breast01?

The FDA has recently approved datopotamab deruxtecan-dlnk (Dato-DXd), an antibody-drug conjugate, for adults with unresectable or metastatic, hormone receptor-positive, HER2-negative breast cancer who…

Article · @KolPulseAI
1
2
503
Load more